Concepedia

Jurij Hanžel

JH

Statistics

Publications

25

Citations

1.3K

H-Index

20

Active since

2012

Affiliations

University of Ljubljana(Current)

Ljubljana University Medical Centre

KU Leuven

Amsterdam University Medical Centers

University of Calgary

Jurij Hanžel is an author at University of Ljubljana specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and crohn disease pharmacotherapy.

ORCID

Publications per year

2012–2024

25

Publications

25

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Hannah Gordon, Silvia Minozzi, Uri Kopylov et al. · Journal of Crohn s and Colitis · 2024 · 315 citations · Full text

, , +16

ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

Michel Adamina, Silvia Minozzi, Janindra Warusavitarne et al. · Journal of Crohn s and Colitis · 2024 · 145 citations · Full text

, , +12

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

Ahmed Almradi, Jurij Hanžel, Rocío Sedaño et al. · BioDrugs · 2020 · 100 citations

, , +16

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Uri Kopylov, Jurij Hanžel, Claire Liefferinckx et al. · Alimentary Pharmacology & Therapeutics · 2020 · 80 citations · Full text

, , +5

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Christopher Ma, Jurij Hanžel, Remo Panaccione et al. · Gastroenterology · 2022 · 79 citations · Full text

, , +12

1–5 of 25